Literature DB >> 10361246

Rapid conversion of naive to effector T cell function counteracts diminished primary human newborn T cell responses.

E Early1, D J Reen.   

Abstract

The reduced incidence of graft versus host disease following the use of human cord blood as a source of stem cells for bone marrow reconstitution challenges our understanding of the immunocompetence of newborn T cells. Newborn CD4+ T cells express mainly the CD45RA phenotype and have been considered to respond comparably to adult CD4+ T cells exhibiting the CD45RA phenotype. We compared the in vitro kinetics of phenotypic conversion of newborn and adult CD4+CD45RA+ T cells to CD4+CD45RO+ T cells. The cytokine profile and B cell helper activity of the converted CD4+CD45RO+ T cell population were also determined. Newborn CD4+CD45RA+ T cells were converted to CD4+CD45RO+ with significantly faster time kinetics than adult CD4+CD45RA+ T cells, following either phytohaemagglutinin (PHA) or anti-CD2 activation. Freshly purified newborn naive T cells did not produce IL-2, IL-4 or interferon-gamma (IFN-gamma) following stimulation, whereas adult naive T cells secreted IL-2 and adult-derived CD4+CD45RO+ T cells secreted all three cytokines under the same stimulatory conditions. However, newborn and adult CD4+CD45RA+ T cells, following primary stimulation and maturation in vitro, acquired the ability to secrete a Th1-type cytokine profile of IL-2 and IFN-gamma after secondary stimulation. Newborn CD4+ naive T cells that acquired the CD45RO phenotype in vitro also gained B cell helper activity equivalent to that of adult in vitro matured CD4+ naive T cells. These findings suggest that newborn and adult CD4+CD45RA+ T cell subsets are differentially responsive to various stimuli. They show that newborn CD4+CD45RA+ naive T cells can transform more quickly than their adult counterparts into functionally equivalent CD4+CD45RO+ T cells, a process that may be important to counteract the immature immune environment which exists in the newborn.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10361246      PMCID: PMC1905313          DOI: 10.1046/j.1365-2249.1999.00920.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  T cell activation via CD2 [T, gp50] molecules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/T11(1) epitopes.

Authors:  P Brottier; L Boumsell; C Gelin; A Bernard
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

2.  T cell activation via CD2 [T, gp50]: the role of accessory cells in activating resting T cells via CD2.

Authors:  S Huet; H Wakasugi; G Sterkers; J Gilmour; T Tursz; L Boumsell; A Bernard
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

3.  Surface activation markers of T lymphocytes: role in the detection of infection in neonates.

Authors:  S Hodge; G Hodge; R Flower; P Han
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

4.  Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event.

Authors:  H M Serra; J F Krowka; J A Ledbetter; L M Pilarski
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

5.  An improved rosetting assay for detection of human T lymphocytes.

Authors:  M E Kaplan; C Clark
Journal:  J Immunol Methods       Date:  1974-07       Impact factor: 2.303

6.  Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells.

Authors:  A N Akbar; L Terry; A Timms; P C Beverley; G Janossy
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

7.  Defective IFN-gamma production in the human neonate. II. Role of increased sensitivity to the suppressive effects of prostaglandin E.

Authors:  N Wakasugi; J L Virelizier; F Arenzana-Seisdedos; B Rothhut; J M Huerta; F Russo-Marie; W Fiers
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

8.  Neonatal infections. An important determinant of late NICU mortality in infants less than 1,000 g at birth.

Authors:  E F La Gamma; L M Drusin; A W Mackles; S Machalek; P A Auld
Journal:  Am J Dis Child       Date:  1983-09

9.  Neonatal septicaemia.

Authors:  T Vesikari; M Janas; P Grönroos; N Tuppurainen; M Renlund; P Kero; M Koivisto; M Kunnas; K Heinonen; R Nyman
Journal:  Arch Dis Child       Date:  1985-06       Impact factor: 3.791

10.  Dissociated production of interleukin-2 and immune (gamma) interferon by phytohaemagglutinin stimulated lymphocytes in healthy infants.

Authors:  T Miyawaki; H Seki; K Taga; H Sato; N Taniguchi
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

View more
  7 in total

Review 1.  Type 1 and type 2 immune responses in children: their relevance in juvenile arthritis.

Authors:  L R Wedderburn; P Woo
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Selective deficiency in protein kinase C isoenzyme expression and inadequacy in mitogen-activated protein kinase activation in cord blood T cells.

Authors:  Charles S T Hii; Maurizio Costabile; George C Mayne; Channing J Der; Andrew W Murray; Antonio Ferrante
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

Review 3.  Reconstitution of adaptive immunity after umbilical cord blood transplantation: impact on infectious complications.

Authors:  Sophie Servais; Muriel Hannon; Régis Peffault de Latour; Gérard Socie; Yves Beguin
Journal:  Stem Cell Investig       Date:  2017-05-25

4.  Validation of monoclonal anti-PKC isozyme antibodies for flow cytometry analyses in human T cell subsets and expression in cord blood T cells.

Authors:  Khalida Perveen; Alex Quach; Andrew McPhee; Susan L Prescott; Simon C Barry; Charles S Hii; Antonio Ferrante
Journal:  Sci Rep       Date:  2019-06-25       Impact factor: 4.379

Review 5.  Clinical Relevance of Immunobiology in Umbilical Cord Blood Transplantation.

Authors:  Hyun Don Yun; Ankur Varma; Mohammad J Hussain; Sunita Nathan; Claudio Brunstein
Journal:  J Clin Med       Date:  2019-11-14       Impact factor: 4.241

6.  Insulin-like growth factor I promotes cord blood T cell maturation through monocytes and inhibits their apoptosis in part through interleukin-6.

Authors:  Helen K W Law; Wenwei Tu; Enmei Liu; Yu Lung Lau
Journal:  BMC Immunol       Date:  2008-12-17       Impact factor: 3.615

7.  Methamphetamine functions as a novel CD4+ T-cell activator via the sigma-1 receptor to enhance HIV-1 infection.

Authors:  Anil Prasad; Rutuja Kulkarni; Ashutosh Shrivastava; Shuxian Jiang; Kaycie Lawson; Jerome E Groopman
Journal:  Sci Rep       Date:  2019-01-30       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.